Clinical trial recruitment faces persistent challenges, including prolonged enrollment periods, high screen failure rates, and inconsistent data quality. This session introduces the innovative block enrollment strategy, which accelerates trial recruitment by concentrating all site resources on a single protocol during a focused enrollment period. By aligning the entire research team and optimizing patient engagement, the block enrollment approach improves enrollment efficiency, reduces screen failures, and enhances participant retention. Drawing on real-world data from ophthalmic trials, attendees will explore how this model streamlines workflows while maintaining rigorous quality standards. The session will engage participants in discussing scalability and adaptation of block enrollment across various therapeutic areas. Key roles of principal investigators, study coordinators, and support staff in this focused recruitment method will be highlighted. Attendees will have the opportunity to learn about a transformative, practical approach that reshapes clinical trial enrollment and optimizes site performance.

CEU: 1.00 ACRP

Speaker:

• David Almeida, MD, MBA, PhD, President and CEO, Centers for Advanced Surgical Exploration (CASEx) and Erie Retina Research